Connect with us

Health

Potency-enhancing drugs show ability to improve prognosis in patients with colorectal cancer – News-Medical.Net

A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.

Published

on

A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. PDE5 inhibitors include a few approved drugs in which sildenafil (Viagra) is the most well-known. The article is published in Nature Communications.
Available preclinical evidence suggests that PDE5 inhibitors could slow down the tumor growth and progression in mice, but it is…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending